Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05062980 |
| Title | Reqorsa (Quaratusugene Ozeplasmid) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer (Acclaim-2) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Genprex, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Moffitt Cancer Center - Magnolia Campus | Recruiting | Tampa | Florida | 33612 | United States | Details |
| Washington University School of Medicine - Siteman Cancer Center | Recruiting | Saint Louis | Missouri | 63110 | United States | Details |
| Millennium Oncology | Recruiting | Houston | Texas | 77090 | United States | Details |